Psychometric Properties of the Polish version of the Drug-Use Disorders Identification Test
Psychometric Properties of the Polish version of the Drug-Use Disorders Identification Test
复制标题
DOI：
10.1159/000506156
复制
发表时间：
2020-05-01
影响因子：
3.9
通讯作者：
Wojnar, Marcin
中科院分区：
文献类型：
--
作者：
Klimkiewicz, Anna;Jakubczyk, Andrzej;Wojnar, Marcin
背景：物质使用是世界范围内日益严重的问题，非常需要制定预防和治疗物质使用障碍（SUD）的国家政策。然而，由于缺乏一种常用的、有价值的诊断工具来评估 SUD 的症状，因此无法对吸毒问题的普遍程度以及不同国家所采用的政策策略的有效性进行比较。这项研究的目的是验证一种常用量表——药物使用障碍识别测试（DUDIT）在波兰的使用情况。目的：本研究的目的是测试 DUDIT 在波兰人群中的可靠性，确认该工具因子结构的相对稳定性，并验证之前提出的 DUDIT 截止评分。方法：吸毒者组包括 127 名诊断为 SUD 的 19-40 岁患者（平均年龄 30.37，SD 6.36），对照组包括 533 名 19-25 岁学生（平均年龄 20.72，SD 1.88）。所有参与者都完成了波兰语版本的 DUDIT。确定了波兰版 DUDIT 的内部一致性，随后进行了外部验证。结果：分析表明，波兰版 DUDIT 具有良好的基于 Cronbach's alpha 的信度，值为 0.92。组间比较显示对照组和物质依赖患者之间存在显着差异，对应于较大的效应量（Cohen's d = 3.27）。将 DUDIT 评分与 SUD 的 ICD-10 诊断进行比较的接受者操作特征分析显示，最佳截止值为 7 分，敏感性为 0.929，特异性为 0.974。结论：这些结果构成了初步证据，表明波兰版 DUDIT 可能是波兰人群药物使用障碍的有效且可靠的筛查工具。
Background: Substance use is a growing problem worldwide, and there is a great need to develop national policies addressing prevention and treatment of substance-use disorders (SUD). However, the lack of a commonly used, valuable diagnostic tool to assess the symptoms of SUDs precludes comparison of the prevalence of drug-use problems as well as the efficacy of policy strategies applied in different countries. This study was conducted to validate one of the commonly used scales the Drug Use Disorders Identification Test (the DUDIT) for use in Polish condition. Objectives: The aims of this study were to test the reliability of the DUDIT in the Polish population, to confirm the comparative stability of the factor structure of the instrument, and to verify previously proposed DUDIT cutoff scoring. Methods: The group of drug users comprised 127 patients aged 19-40 years (mean age 30.37, SD 6.36) with a diagnosis of SUD, while the control group consisted of 533 students aged 19-25 years (mean age 20.72, SD 1.88). All participants completed the Polish version of the DUDIT. Internal consistency of the Polish version of the DUDIT was determined, and subsequently external validation was performed. Results: Analysis showed that the Polish version of the DUDIT was characterized by a good reliability based on Cronbach's alpha, with a value of 0.92. The between-group comparison revealed a significant difference between the control group and substance-dependent patients corresponding to a large effect size (Cohen's d = 3.27). The receiver-operating characteristic analysis, comparing the DUDIT score to the ICD-10 diagnosis of SUD, showed an optimal cutoff value of 7 points, with a sensitivity of 0.929 and a specificity of 0.974. Conclusion: These results constitute preliminary evidence that the Polish version of the DUDIT may be a valid and reliable screening tool for drug-use disorders in the Polish population.